Effects of a GnRH cytotoxin on reproductive function in peripubertal male dogs

Barry A. Ball, Khalida Sabeur, Terry Nett, Irwin Liu

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Methods for long-term or permanent disruption of reproductive function via nonsurgical techniques are needed for a variety of species, including companion animals. In a previous study, we demonstrated the ability of a cytotoxin (pokeweed antiviral protein-PAP) conjugated to d-Lys6-GnRH, to disrupt reproductive function in adult male dogs. The objective of the present study was to examine the ability of a d-Lys6-GnRH-PAP conjugate to disrupt reproductive function in peripubertal male dogs. Peripubertal male dogs (n = 15; approximately 16-32 weeks old) were treated with d-Lys6-GnRH-PAP as follows: dogs (n = 7; Group I) received GnRH-PAP (0.1 mg/kg SQ) with a second treatment (0.25 mg/kg) 20 weeks later. An additional group (n = 3; Group II) of peripubertal dogs was treated with GnRH-PAP (0.25 mg/kg) twice (20 weeks apart). Control dogs (n = 5) received d-Lys6-GnRH analog (0.0045 mg/kg SQ) without PAP. Efficacy was assessed by monitoring testis size, serum concentrations of testosterone and LH, as well as LH release subsequent to a GnRH (5 μg/kg) stimulus. Dogs in Group I (n = 5) that did not respond to the initial two treatments were given a third GnRH-PAP injection (0.25 mg/kg), 12 months after the initial treatment. The initial GnRH-PAP treatment in peripubertal male dogs did not affect testis growth, LH release or serum testosterone concentrations; however, administration of a higher dose of GnRH-PAP after puberty resulted in a marked and rapid decline in testis size, serum testosterone concentrations and LH responsiveness to GnRH stimulation in 9 of 10 dogs. Suppression of reproductive function was maintained in treated dogs for 18-50 weeks; four dogs had suppression of reproductive activity through the end of the study. In conclusion, GnRH-PAP given after puberty markedly suppressed reproductive activity. Due to variability in the response and duration of suppression after treatment with GnRH-PAP, more research is required to determine its efficacy for nonsurgical sterilization of the male dog.

Original languageEnglish (US)
Pages (from-to)766-774
Number of pages9
JournalTheriogenology
Volume66
Issue number4
DOIs
StatePublished - Sep 1 2006

Fingerprint

cytotoxins
Cytotoxins
Gonadotropin-Releasing Hormone
Dogs
dogs
testosterone
testes
Testosterone
Testis
puberty
Puberty
antiviral proteins
Serum
Reproductive Sterilization
Phytolacca americana
Therapeutics
Pets
pets

Keywords

  • Cytotoxin
  • GnRH
  • Male dog
  • Sterilization
  • Testis

ASJC Scopus subject areas

  • Small Animals
  • Food Animals
  • Animal Science and Zoology
  • Equine

Cite this

Effects of a GnRH cytotoxin on reproductive function in peripubertal male dogs. / Ball, Barry A.; Sabeur, Khalida; Nett, Terry; Liu, Irwin.

In: Theriogenology, Vol. 66, No. 4, 01.09.2006, p. 766-774.

Research output: Contribution to journalArticle

Ball, Barry A. ; Sabeur, Khalida ; Nett, Terry ; Liu, Irwin. / Effects of a GnRH cytotoxin on reproductive function in peripubertal male dogs. In: Theriogenology. 2006 ; Vol. 66, No. 4. pp. 766-774.
@article{807fe3f8319b492582d31ee233aeff19,
title = "Effects of a GnRH cytotoxin on reproductive function in peripubertal male dogs",
abstract = "Methods for long-term or permanent disruption of reproductive function via nonsurgical techniques are needed for a variety of species, including companion animals. In a previous study, we demonstrated the ability of a cytotoxin (pokeweed antiviral protein-PAP) conjugated to d-Lys6-GnRH, to disrupt reproductive function in adult male dogs. The objective of the present study was to examine the ability of a d-Lys6-GnRH-PAP conjugate to disrupt reproductive function in peripubertal male dogs. Peripubertal male dogs (n = 15; approximately 16-32 weeks old) were treated with d-Lys6-GnRH-PAP as follows: dogs (n = 7; Group I) received GnRH-PAP (0.1 mg/kg SQ) with a second treatment (0.25 mg/kg) 20 weeks later. An additional group (n = 3; Group II) of peripubertal dogs was treated with GnRH-PAP (0.25 mg/kg) twice (20 weeks apart). Control dogs (n = 5) received d-Lys6-GnRH analog (0.0045 mg/kg SQ) without PAP. Efficacy was assessed by monitoring testis size, serum concentrations of testosterone and LH, as well as LH release subsequent to a GnRH (5 μg/kg) stimulus. Dogs in Group I (n = 5) that did not respond to the initial two treatments were given a third GnRH-PAP injection (0.25 mg/kg), 12 months after the initial treatment. The initial GnRH-PAP treatment in peripubertal male dogs did not affect testis growth, LH release or serum testosterone concentrations; however, administration of a higher dose of GnRH-PAP after puberty resulted in a marked and rapid decline in testis size, serum testosterone concentrations and LH responsiveness to GnRH stimulation in 9 of 10 dogs. Suppression of reproductive function was maintained in treated dogs for 18-50 weeks; four dogs had suppression of reproductive activity through the end of the study. In conclusion, GnRH-PAP given after puberty markedly suppressed reproductive activity. Due to variability in the response and duration of suppression after treatment with GnRH-PAP, more research is required to determine its efficacy for nonsurgical sterilization of the male dog.",
keywords = "Cytotoxin, GnRH, Male dog, Sterilization, Testis",
author = "Ball, {Barry A.} and Khalida Sabeur and Terry Nett and Irwin Liu",
year = "2006",
month = "9",
day = "1",
doi = "10.1016/j.theriogenology.2005.11.024",
language = "English (US)",
volume = "66",
pages = "766--774",
journal = "Theriogenology",
issn = "0093-691X",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Effects of a GnRH cytotoxin on reproductive function in peripubertal male dogs

AU - Ball, Barry A.

AU - Sabeur, Khalida

AU - Nett, Terry

AU - Liu, Irwin

PY - 2006/9/1

Y1 - 2006/9/1

N2 - Methods for long-term or permanent disruption of reproductive function via nonsurgical techniques are needed for a variety of species, including companion animals. In a previous study, we demonstrated the ability of a cytotoxin (pokeweed antiviral protein-PAP) conjugated to d-Lys6-GnRH, to disrupt reproductive function in adult male dogs. The objective of the present study was to examine the ability of a d-Lys6-GnRH-PAP conjugate to disrupt reproductive function in peripubertal male dogs. Peripubertal male dogs (n = 15; approximately 16-32 weeks old) were treated with d-Lys6-GnRH-PAP as follows: dogs (n = 7; Group I) received GnRH-PAP (0.1 mg/kg SQ) with a second treatment (0.25 mg/kg) 20 weeks later. An additional group (n = 3; Group II) of peripubertal dogs was treated with GnRH-PAP (0.25 mg/kg) twice (20 weeks apart). Control dogs (n = 5) received d-Lys6-GnRH analog (0.0045 mg/kg SQ) without PAP. Efficacy was assessed by monitoring testis size, serum concentrations of testosterone and LH, as well as LH release subsequent to a GnRH (5 μg/kg) stimulus. Dogs in Group I (n = 5) that did not respond to the initial two treatments were given a third GnRH-PAP injection (0.25 mg/kg), 12 months after the initial treatment. The initial GnRH-PAP treatment in peripubertal male dogs did not affect testis growth, LH release or serum testosterone concentrations; however, administration of a higher dose of GnRH-PAP after puberty resulted in a marked and rapid decline in testis size, serum testosterone concentrations and LH responsiveness to GnRH stimulation in 9 of 10 dogs. Suppression of reproductive function was maintained in treated dogs for 18-50 weeks; four dogs had suppression of reproductive activity through the end of the study. In conclusion, GnRH-PAP given after puberty markedly suppressed reproductive activity. Due to variability in the response and duration of suppression after treatment with GnRH-PAP, more research is required to determine its efficacy for nonsurgical sterilization of the male dog.

AB - Methods for long-term or permanent disruption of reproductive function via nonsurgical techniques are needed for a variety of species, including companion animals. In a previous study, we demonstrated the ability of a cytotoxin (pokeweed antiviral protein-PAP) conjugated to d-Lys6-GnRH, to disrupt reproductive function in adult male dogs. The objective of the present study was to examine the ability of a d-Lys6-GnRH-PAP conjugate to disrupt reproductive function in peripubertal male dogs. Peripubertal male dogs (n = 15; approximately 16-32 weeks old) were treated with d-Lys6-GnRH-PAP as follows: dogs (n = 7; Group I) received GnRH-PAP (0.1 mg/kg SQ) with a second treatment (0.25 mg/kg) 20 weeks later. An additional group (n = 3; Group II) of peripubertal dogs was treated with GnRH-PAP (0.25 mg/kg) twice (20 weeks apart). Control dogs (n = 5) received d-Lys6-GnRH analog (0.0045 mg/kg SQ) without PAP. Efficacy was assessed by monitoring testis size, serum concentrations of testosterone and LH, as well as LH release subsequent to a GnRH (5 μg/kg) stimulus. Dogs in Group I (n = 5) that did not respond to the initial two treatments were given a third GnRH-PAP injection (0.25 mg/kg), 12 months after the initial treatment. The initial GnRH-PAP treatment in peripubertal male dogs did not affect testis growth, LH release or serum testosterone concentrations; however, administration of a higher dose of GnRH-PAP after puberty resulted in a marked and rapid decline in testis size, serum testosterone concentrations and LH responsiveness to GnRH stimulation in 9 of 10 dogs. Suppression of reproductive function was maintained in treated dogs for 18-50 weeks; four dogs had suppression of reproductive activity through the end of the study. In conclusion, GnRH-PAP given after puberty markedly suppressed reproductive activity. Due to variability in the response and duration of suppression after treatment with GnRH-PAP, more research is required to determine its efficacy for nonsurgical sterilization of the male dog.

KW - Cytotoxin

KW - GnRH

KW - Male dog

KW - Sterilization

KW - Testis

UR - http://www.scopus.com/inward/record.url?scp=33746921627&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746921627&partnerID=8YFLogxK

U2 - 10.1016/j.theriogenology.2005.11.024

DO - 10.1016/j.theriogenology.2005.11.024

M3 - Article

C2 - 16504280

AN - SCOPUS:33746921627

VL - 66

SP - 766

EP - 774

JO - Theriogenology

JF - Theriogenology

SN - 0093-691X

IS - 4

ER -